These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9356961)

  • 1. Adherence to prescribed HIV-1 protease inhibitors in the home setting.
    Ungvarski P
    J Assoc Nurses AIDS Care; 1997; 8 Suppl():37-45. PubMed ID: 9356961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention.
    Kelly JA; Otto-Salaj LL; Sikkema KJ; Pinkerton SD; Bloom FR
    Health Psychol; 1998 Jul; 17(4):310-9. PubMed ID: 9697940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens.
    Duong M; Piroth L; Grappin M; Forte F; Peytavin G; Buisson M; Chavanet P; Portier H
    HIV Clin Trials; 2001; 2(2):128-35. PubMed ID: 11590521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report.
    Walsh JC; Dalton M; Gazzard BG
    AIDS; 1998 Dec; 12(17):2361-3. PubMed ID: 9863888
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV therapeutics: confronting adherence.
    Katzenstein DA; Lyons C; Molaghan JP; Ungvarski P; Wolfe GS; Williams A
    J Assoc Nurses AIDS Care; 1997; 8 Suppl():46-58. PubMed ID: 9356962
    [No Abstract]   [Full Text] [Related]  

  • 6. Methadone, adherence and protease inhibitors.
    Treat Rev; 1997 Aug; (No 25):2-3. PubMed ID: 11364614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A medication self-management program to improve adherence to HIV therapy regimens.
    Smith SR; Rublein JC; Marcus C; Brock TP; Chesney MA
    Patient Educ Couns; 2003 Jun; 50(2):187-99. PubMed ID: 12781934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe and effective use of combination antiretroviral treatment.
    Colebunders R; Clumeck N; Florence E; Vandercam B; Van Wanzeele F; Van Wijngaerden E; Lacor P; Demonty J; De Wit S
    Acta Clin Belg; 1999 Apr; 54(2):55-60. PubMed ID: 10394641
    [No Abstract]   [Full Text] [Related]  

  • 9. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.
    Walsh JC; Mandalia S; Gazzard BG
    AIDS; 2002 Jan; 16(2):269-77. PubMed ID: 11807312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV resistance: the new enemy.
    Colvin R
    Common Factor; 1997 Nov; (No 11):6-7. PubMed ID: 11364845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV protease inhibitors].
    Rubio R; Romeu J; Viciana P; Redondo C
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():10-4. PubMed ID: 9053020
    [No Abstract]   [Full Text] [Related]  

  • 13. Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.
    Erickson JW; Gulnik SV; Markowitz M
    AIDS; 1999; 13 Suppl A():S189-204. PubMed ID: 10885776
    [No Abstract]   [Full Text] [Related]  

  • 14. Developing long-term treatment strategies.
    PI Perspect; 1996 Sep; (No 19):11-4. PubMed ID: 11363897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient adherence, not viral load now most important in HIV therapy.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(3):6-7. PubMed ID: 11768406
    [No Abstract]   [Full Text] [Related]  

  • 16. Adherence issues in HIV therapeutics. Introduction: the situation.
    Molaghan JB
    J Assoc Nurses AIDS Care; 1997; 8 Suppl():7-9. PubMed ID: 9356956
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term strategies: should some patients wait to start protease inhibitors? Interview with Keith Henry, M.D. Interview by John S. James.
    Henry K
    AIDS Treat News; 1997 Oct; (No 281):1, 3-6. PubMed ID: 11364791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Client Adherence Profiling-Intervention Tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study.
    Holzemer WL; Henry SB; Portillo CJ; Miramontes H
    J Assoc Nurses AIDS Care; 2000; 11(1):36-44. PubMed ID: 10670005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment of HIV infection.
    Thomas MG; Ellis-Pegler RB
    N Z Med J; 1998 Sep; 111(1074):353-4. PubMed ID: 11039818
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.